Abstract:Bullo Saifullah, 1, 2 Palanisamy Arulselvan, 3, 4 Mohamed E El Zowalaty, 3, 5 Woan Sean Tan, 3 Sharida Fakurazi, 6 Thomas J Webster, 7 Rabia Baby, 1 Mohd Zobir Hussein 1 1 Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 2 Department of Management Sciences and Technology, The Begum Nusrat Bhutto Women University Sukkur, Sukkur, Sindh, 65170, Pakistan; 3 Laboratory for Vaccine and Immunotherapeutics, Institute of Biosciences, University Putra Malaysia, Serdang, Selangor, 43400, Malaysia; 4 Muthayammal Centre for Advanced Research, Muthayammal College of Arts and Science, Namakkal, Tamil Nadu, 637408, India; 5 Zoonosis Science Center, Department of Microbiology and Immunology, Uppsala University, Uppsala, Sweden; 6 Department of Human Anatomy, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 7 Department of Chemical Engineering, Northeastern University, Boston, MA, USA Correspondence: Mohd Zobir Hussein Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology, (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia Tel +60 397698092 Email Introduction: Mycobacterium tuberculosis infections are associated with severe local inflammatory reactions, which may be life-threatening and lead to tuberculosis pathogenesis and associated complications. Inorganic nanolayers have been vastly exploited for biomedical applications (especially in drug delivery) because of their biocompatible and biodegradable nature with the ability to release a drug in a sustained manner. Herein, we report a new nanodelivery system of inorganic nanolayers based on magnesium layered hydroxides (MgLH) and a successfully intercalated anti-tuberculosis drug para-aminosalicylic acid (PAS). Methods: The designed anti-tuberculosis nanodelivery composite, MgLH-PAS, was prepared by a novel co-precipitation method using MgNO 3 as well MgO as starting materials. Results: The designed nano-formulation, PAS-MgLH, showed good antimycobacterial and antimicrobial activities with significant synergistic anti-inflammatory effects on the suppression of lipopolysaccharide (LPS) stimulated inflammatory mediators in RAW 264.7 macrophages. The designed nano-formulation was also found to be biocompatible with human normal lung cells (MRC-5) and 3T3 fibroblast cells. Furthermore, the in vitro release of PAS from PAS-MgLH was found to be sustained in human body simulated phosphate buffer saline (PBS) solutions of pH 7.4 and pH 4.8. Discussion: The results of the present study are highly encouraging for further in vivo studies. This new nanodelivery system, MgLH, can be exploited in the delivery of other drugs and in numerous other biomedical applications as well. Keywords: Mycobacterium tuberculosis , magnesium layered hydroxides, biomaterial, sustained release, anti-tuberculosis, anti-inflammatory Tuberculosis is a devastating bacterial infectious disease caused by Mycobacterium tuberculosis (MTB) or tubercle bacilli. 1 It existed for centuries and despite technological advancements, we have still not been able to eradicate it. There are only two new drugs that have been found for tuberculosis treatment in the last five decades. 2 With the currently best available anti-TB drugs, the treatment lasts from 6 to 24 months, depending on the type of TB disease. 3 According to the latest global tuberculosis report in 2020, there were about 10 million new incidents of TB cases worldwide in the year 2019. There were an estimated 1.2 million (range, 1.1–1.3 million) TB deaths among HIV-negative people in 2019. 1 Tuberculosis is associated with a severe local inflammatory reaction which may be life-threatening and leads to pathogenesis and associated complications. This results in the activation of the innate immune response components and the main recruiters of immune cells, such as polymorphonuclear and mononuclear phagocytes. It also results in the stimulation of numerous primary pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin 6, and interleukin 1β by the mycobacterium. 4–7 These inflammatory reactions cause severe damage to the site of the infection. 5–7 In the present study, we investigated the anti-inflammatory potential of these nanocomposites on LPS-stimulated RAW 264.7 macrophages. PAS is an effective drug, but because of its side effects such as epigastric distress, nausea, anorex -Abstract Truncated-

Lower Cytotoxicity, High Stability, and Long-Term Antibacterial Activity of a Poly(methacrylic Acid)/isoniazid/rifampin Nanogel Against Multidrug-Resistant Intestinal Mycobacterium Tuberculosis.

Genipin-crosslinked Carboxymethyl Chitosan Nanogel for Lung-Targeted Delivery of Isoniazid and Rifampin.

Design and in Vitro Evaluation of a Novel Poly(methacrylic Acid)/metronidazole Antibacterial Nanogel As an Oral Dosage Form.

Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant Mycobacterium tuberculosis

Fabrication and in vitro–in vivo evaluation of ligand appended isoniazid loaded nanoparticulate systems for the treatment of tuberculosis

Multivalent Antimicrobial Polymer Nanoparticles Target Mycobacteria and Gram-Negative Bacteria by Distinct Mechanisms

A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis

Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel

A Novel Para-Amino Salicylic Acid Magnesium Layered Hydroxide Nanocomposite Anti-Tuberculosis Drug Delivery System with Enhanced in vitro Therapeutic and Anti-Inflammatory Properties

Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis

Integration of Antimicrobial Peptides and Gold Nanorods for Bimodal Antibacterial Applications.

Production of Polylactide Nanoparticles Loaded With Isoniazid and Vitamin C: A Promising Candidate for the Treatment of Resistant Forms of Tuberculosis

Microencapsulated Isoniazid-Loaded Metal-Organic Frameworks for Pulmonary Administration of Antituberculosis Drugs

Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis

Immune Response to Antituberculosis Drug-Loaded Gelatin and Polyisobutyl-Cyanoacrylate Nanoparticles in Macrophages.

In vitro and in vivo evaluation of antibacterial activity of polyhexamethylene guanidine (PHMG)-loaded TiO2 nanotubes.

The Use of Poly(methacrylic Acid) Nanogel to Control the Release of Amoxycillin with Lower Cytotoxicity.

Optimization of Polylactide-Co-Glycolide-Rifampicin Nanoparticle Synthesis, In Vitro Study of Mucoadhesion and Drug Release

Bio-evaluation of poly(lactic-co-glycolic) acid nanoparticles loaded with radiolabelled rifampicin

Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens

Mucoadhesive Polymer Tangeretin Loaded Chitosan Nanoparticles to Combat the Resistance of Mycobacterium Tuberculosis